Detalhe da pesquisa
1.
The role and mechanism of RIPK1 in vascular endothelial dysfunction in chronic kidney disease.
FASEB J
; 38(2): e23446, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38275125
2.
FTO-mediated m6A modification of serum amyloid A2 mRNA promotes podocyte injury and inflammation by activating the NF-κB signaling pathway.
FASEB J
; 38(2): e23409, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193628
3.
N6-methyladenosine methylation in kidney injury.
Clin Epigenetics
; 15(1): 170, 2023 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865763
4.
T cells and their products in diabetic kidney disease.
Front Immunol
; 14: 1084448, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776877
5.
Inhibition of the lncRNA 585189 prevents podocyte injury and mitochondria dysfunction by promoting hnRNP A1 and SIRT1 in diabetic nephropathy.
Mol Cell Endocrinol
; 578: 112065, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37690472
6.
ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis.
Redox Biol
; 62: 102674, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36989575